Although South Africa had to suspend the use of the Astra-Zeneca vaccine, this led to the country possibly being able to vaccinate its people against the virus much faster, by using the Johnson & Johnson vaccine.

This is according to Aspen Pharma-Care CEO and founder Stephen Saad who says the simplicity of the J&J vaccine (which requires only one injection dose) can help government vaccinate millions of South Africans in a shorter period of time.

Saad spoke to eNCA and says the use of the J&J vaccine will help the country “catch up” with other countries much faster.

Chief Executive, Stephen Saad addressed President Ramaphosa and his Delegation at Aspen’s sterile facility in Gqberha, Eastern Cape earlier today.#AspenWeCare#WeAreVaccinationhttps://t.co/ewvOD5RhA4

— Aspen Pharma (@aspenpharma) March 29, 2021